We do need some tariffs, applied strategically and predictably [Los Angeles Times (CA)]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Los Angeles Times
economists all agree tariffs are terrible!” And perhaps they do — or at least most of them do. Barriers to free and unfettered trade may well appear inefficient as a matter of an economic model's deadweight loss — and they may well conflict with David Ricardo's much-heralded 19th century trade theory of comparative advantage. It may well be the case that consumer surplus is indeed harmed by restrictions on the free flow of goods. But this is classroom theory. And the “dismal science” that is the economics profession is not always known for its close relationship to, well, real life. After the fall of the Berlin Wall, elites of both parties in the U.S., overly confident in their conviction that Western openness had just defeated the Soviet “Evil Empire,” rushed to implement a Washington Consensus of globalization and trade liberalization — on all kinds of products, ending selective Reagan-era trade barriers to, for instance, Japanese cars. An advisor to President George H.W. Bush m
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care* [Yahoo! Finance]Yahoo! Finance
- U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*PR Newswire
- These Institutional Investors Are Raising Their Stakes in Johnson & Johnson Stock. Should You Do the Same? [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (NYSE:JNJ) was given a new $197.00 price target on by analysts at Morgan Stanley.MarketBeat
- Is J&J's 45.8% 2025 Surge Justified by Its Cash Flow and Earnings Outlook? [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 10/14/25 - Beat
JNJ
Sec Filings
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- JNJ's page on the SEC website